407 related articles for article (PubMed ID: 28605109)
21. Acute and continuation risperidone monotherapy in mania.
Vieta E; Brugué E; Goikolea JM; Sánchez-Moreno J; Reinares M; Comes M; Colom F; Martínez-Arán A; Benabarre A; Torrent C
Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711
[TBL] [Abstract][Full Text] [Related]
22. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study.
Khanna S; Vieta E; Lyons B; Grossman F; Eerdekens M; Kramer M
Br J Psychiatry; 2005 Sep; 187():229-34. PubMed ID: 16135859
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
Weisler RH; Kalali AH; Ketter TA;
J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
[TBL] [Abstract][Full Text] [Related]
24. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
Miller DS; Yatham LN; Lam RW
J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
[TBL] [Abstract][Full Text] [Related]
26. Risperidone in acute and continuation treatment of mania.
Yatham LN; Binder C; Riccardelli R; Leblanc J; Connolly M; Kusumakar V;
Int Clin Psychopharmacol; 2003 Jul; 18(4):227-35. PubMed ID: 12817157
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
28. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
[TBL] [Abstract][Full Text] [Related]
29. An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.
Hirschfeld RM; Eerdekens M; Kalali AH; Canuso CM; Khan AA; Karcher K; Palumbo JM
Int Clin Psychopharmacol; 2006 Jan; 21(1):11-20. PubMed ID: 16317312
[TBL] [Abstract][Full Text] [Related]
30. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
Sachs GS; Greenberg WM; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
J Affect Disord; 2015 Mar; 174():296-302. PubMed ID: 25532076
[TBL] [Abstract][Full Text] [Related]
31. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
[TBL] [Abstract][Full Text] [Related]
32. A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania.
Mousavi SY; Khezri R; Karkhaneh-Yousefi MA; Mohammadinejad P; Gholamian F; Mohammadi MR; Zeinoddini A; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):494-500. PubMed ID: 28409660
[TBL] [Abstract][Full Text] [Related]
33. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
[TBL] [Abstract][Full Text] [Related]
34. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
[TBL] [Abstract][Full Text] [Related]
35. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
[TBL] [Abstract][Full Text] [Related]
36. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
Yatham LN; Fallu A; Binder CE
Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
[TBL] [Abstract][Full Text] [Related]
37. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
[TBL] [Abstract][Full Text] [Related]
38. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
[TBL] [Abstract][Full Text] [Related]
39. Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
Berk M; Ng F; Wang WV; Tohen M; Lubman DI; Vieta E; Dodd S
J Affect Disord; 2008 Sep; 110(1-2):126-34. PubMed ID: 18280579
[TBL] [Abstract][Full Text] [Related]
40. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
Sharpley AL; Williams C; Holder AA; Godlewska BR; Singh N; Shanyinde M; MacDonald O; Cowen PJ
Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
